Market Overview:

The global coronary stents market size reached US$ 9.73 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 14.4 Billion by 2027, exhibiting a growth rate (CAGR) of 6.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Coronary stents are small, self-expanding tubular metallic devices introduced inside narrow coronary arteries to keep them open after a balloon angioplasty procedure. These stents are coated with a medication, which is slowly released to prevent the walls of arteries from plaque buildup and re-narrowing. They also alleviate heart disease symptoms, such as chest pain and shortness of breath, and allow normal flow of blood and oxygen to the heart. As they are minimally invasive (MI) and require shorter recovery time, coronary stents are gaining traction over coronary artery bypass surgeries around the world.

Coronary Stents Market Trends:

The growing incidence of diabetes, obesity and high blood pressure (BP) is escalating the risk of atherosclerosis disease. This, along with the rising geriatric population, which is more likely to develop cardiovascular diseases (CVDs), represents one of the significant factors impelling the growth of the coronary stent market. Apart from this, the growing popularity of minimally invasive surgeries (MIS) is resulting in the increasing adoption of coronary stents that involve small incision wounds, short hospital stays and fast recovery. Other factors contributing to the market growth include the development of bifurcated stents, improving healthcare infrastructure and rising manufacturing of products using biodegradable materials. Furthermore, the leading market players are introducing advanced products, which is anticipated to drive the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global coronary stents market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, biomaterial, mode of delivery and end user.

Breakup by Type:

• Drug-eluting Stents
• Bare-metal Coronary Stents
• Bioabsorbable Stents
   

Breakup by Biomaterial:

• Metallic Biomaterial
• Polymeric Biomaterial
• Natural Biomaterial
   

Breakup by Mode of Delivery:

• Balloon-expandable Stents
• Self-expanding Stents
   

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Terumo Corporation and Translumina GmbH.

Report Coverage:

Key Questions Answered in This Report:

• How has the global coronary stents market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global coronary stents market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the biomaterial?
• What is the breakup of the market based on the mode of delivery?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global coronary stents market and who are the key players?
• What is the degree of competition in the industry?